APO Research
Talk to an analyst

APO RESEARCH · REPORT

EPA & DHA (Omega 3) Ingredients

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global EPA & DHA (Omega 3) Ingredients Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchEPA & DHA (Omega 3) Ingredients Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal EPA & DHA (Omega 3) Ingredients Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal EPA & DHA (Omega 3) Ingredients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EPA & DHA (Omega 3) Ingredients Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal EPA & DHA (Omega 3) Ingredients Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global EPA & DHA (Omega 3) Ingredients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for EPA & DHA (Omega 3) Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EPA & DHA (Omega 3) Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EPA & DHA (Omega 3) Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the EPA & DHA (Omega 3) Ingredients market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the EPA & DHA (Omega 3) Ingredients market include Lonza, Omega Protein, Martek, GC Rieber Oils, DSM, Croda, BASF, Axellus and Algae EPAX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global EPA & DHA (Omega 3) Ingredients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EPA & DHA (Omega 3) Ingredients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EPA & DHA (Omega 3) Ingredients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EPA & DHA (Omega 3) Ingredients market size, projected growth trends, production technologies, key applications, and end-use industries.

EPA & DHA (Omega 3) Ingredients Segment by Company

Lonza

Omega Protein

Martek

GC Rieber Oils

DSM

Croda

BASF

Axellus

Algae EPAX

Aker BioMarine

EPA & DHA (Omega 3) Ingredients Segment by Type

Low Concentrates

Anchovy/Sardine

High Concentrates

Salmon Oil

Algae Oil

Cod Liver Oil

Medium Concentrates

EPA & DHA (Omega 3) Ingredients Segment by Application

Infant Formulas

Pharmaceuticals

Dietary Supplements

Functional Foods

Pet & Animal Feed

EPA & DHA (Omega 3) Ingredients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global EPA & DHA (Omega 3) Ingredients status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions EPA & DHA (Omega 3) Ingredients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify EPA & DHA (Omega 3) Ingredients significant trends, drivers, influence factors in global and regions.

6. To analyze EPA & DHA (Omega 3) Ingredients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA & DHA (Omega 3) Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EPA & DHA (Omega 3) Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA & DHA (Omega 3) Ingredients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the EPA & DHA (Omega 3) Ingredients market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EPA & DHA (Omega 3) Ingredients industry.

Chapter 3: Detailed analysis of EPA & DHA (Omega 3) Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of EPA & DHA (Omega 3) Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of EPA & DHA (Omega 3) Ingredients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. EPA & DHA (Omega 3) Ingredients Industry Trends Table 2. EPA & DHA (Omega 3) Ingredients Industry Drivers Table 3. EPA & DHA (Omega 3) Ingredients Industry Opportunities and Challenges Table 4. EPA & DHA (Omega 3) Ingredients Industry Restraints Table 5. Global EPA & DHA (Omega 3) Ingredients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global EPA & DHA (Omega 3) Ingredients Revenue Share by Company (2021-2026) Table 7. Global EPA & DHA (Omega 3) Ingredients Sales Volume by Company (k tons) & (2021-2026) Table 8. Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Company (2021-2026) Table 9. Global EPA & DHA (Omega 3) Ingredients Average Price (US$/ton) of Company (2021-2026) Table 10. Global EPA & DHA (Omega 3) Ingredients Company Ranking, (2024-2026) & (USD Million) Table 11. Global EPA & DHA (Omega 3) Ingredients Key Company Manufacturing Base & Headquarters Table 12. Global EPA & DHA (Omega 3) Ingredients Company, Product Type & Application Table 13. Global EPA & DHA (Omega 3) Ingredients Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global EPA & DHA (Omega 3) Ingredients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Low Concentrates Table 18. Significant Companies of Anchovy/Sardine Table 19. Significant Companies of High Concentrates Table 20. Significant Companies of Salmon Oil Table 21. Significant Companies of Algae Oil Table 22. Significant Companies of Cod Liver Oil Table 23. Significant Companies of Medium Concentrates Table 24. Global EPA & DHA (Omega 3) Ingredients Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 25. Global EPA & DHA (Omega 3) Ingredients Sales Volume by Type (2021-2026) & (k tons) Table 26. Global EPA & DHA (Omega 3) Ingredients Sales Volume by Type (2027-2032) & (k tons) Table 27. Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Type (2021-2026) Table 28. Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Type (2027-2032) Table 29. Global EPA & DHA (Omega 3) Ingredients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global EPA & DHA (Omega 3) Ingredients Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global EPA & DHA (Omega 3) Ingredients Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Type (2021-2026) Table 33. Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Infant Formulas Table 35. Significant Companies of Pharmaceuticals Table 36. Significant Companies of Dietary Supplements Table 37. Significant Companies of Functional Foods Table 38. Significant Companies of Pet & Animal Feed Table 39. Global EPA & DHA (Omega 3) Ingredients Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 40. Global EPA & DHA (Omega 3) Ingredients Sales Volume by Application (2021-2026) & (k tons) Table 41. Global EPA & DHA (Omega 3) Ingredients Sales Volume by Application (2027-2032) & (k tons) Table 42. Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Application (2021-2026) Table 43. Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Application (2027-2032) Table 44. Global EPA & DHA (Omega 3) Ingredients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global EPA & DHA (Omega 3) Ingredients Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global EPA & DHA (Omega 3) Ingredients Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Application (2021-2026) Table 48. Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Application (2027-2032) Table 49. Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 50. Global EPA & DHA (Omega 3) Ingredients Sales by Region (2021-2026) & (k tons) Table 51. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Region (2021-2026) Table 52. Global EPA & DHA (Omega 3) Ingredients Sales by Region (2027-2032) & (k tons) Table 53. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Region (2027-2032) Table 54. Global EPA & DHA (Omega 3) Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global EPA & DHA (Omega 3) Ingredients Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Region (2021-2026) Table 57. Global EPA & DHA (Omega 3) Ingredients Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Region (2027-2032) Table 59. Global EPA & DHA (Omega 3) Ingredients Market Average Price (US$/ton) by Region (2021-2026) Table 60. Global EPA & DHA (Omega 3) Ingredients Market Average Price (US$/ton) by Region (2027-2032) Table 61. Global EPA & DHA (Omega 3) Ingredients Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 62. Global EPA & DHA (Omega 3) Ingredients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026) & (k tons) Table 64. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Country (2021-2026) Table 65. Global EPA & DHA (Omega 3) Ingredients Sales by Country (2027-2032) & (k tons) Table 66. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Country (2027-2032) Table 67. Global EPA & DHA (Omega 3) Ingredients Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global EPA & DHA (Omega 3) Ingredients Sales Value Market Share by Country (2021-2026) Table 69. Global EPA & DHA (Omega 3) Ingredients Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global EPA & DHA (Omega 3) Ingredients Sales Value Market Share by Country (2027-2032) Table 71. Lonza Company Information Table 72. Lonza Business Overview Table 73. Lonza EPA & DHA (Omega 3) Ingredients Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Lonza EPA & DHA (Omega 3) Ingredients Product Portfolio Table 75. Lonza Recent Development Table 76. Omega Protein Company Information Table 77. Omega Protein Business Overview Table 78. Omega Protein EPA & DHA (Omega 3) Ingredients Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Omega Protein EPA & DHA (Omega 3) Ingredients Product Portfolio Table 80. Omega Protein Recent Development Table 81. Martek Company Information Table 82. Martek Business Overview Table 83. Martek EPA & DHA (Omega 3) Ingredients Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Martek EPA & DHA (Omega 3) Ingredients Product Portfolio Table 85. Martek Recent Development Table 86. GC Rieber Oils Company Information Table 87. GC Rieber Oils Business Overview Table 88. GC Rieber Oils EPA & DHA (Omega 3) Ingredients Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. GC Rieber Oils EPA & DHA (Omega 3) Ingredients Product Portfolio Table 90. GC Rieber Oils Recent Development Table 91. DSM Company Information Table 92. DSM Business Overview Table 93. DSM EPA & DHA (Omega 3) Ingredients Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. DSM EPA & DHA (Omega 3) Ingredients Product Portfolio Table 95. DSM Recent Development Table 96. Croda Company Information Table 97. Croda Business Overview Table 98. Croda EPA & DHA (Omega 3) Ingredients Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 99. Croda EPA & DHA (Omega 3) Ingredients Product Portfolio Table 100. Croda Recent Development Table 101. BASF Company Information Table 102. BASF Business Overview Table 103. BASF EPA & DHA (Omega 3) Ingredients Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 104. BASF EPA & DHA (Omega 3) Ingredients Product Portfolio Table 105. BASF Recent Development Table 106. Axellus Company Information Table 107. Axellus Business Overview Table 108. Axellus EPA & DHA (Omega 3) Ingredients Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 109. Axellus EPA & DHA (Omega 3) Ingredients Product Portfolio Table 110. Axellus Recent Development Table 111. Algae EPAX Company Information Table 112. Algae EPAX Business Overview Table 113. Algae EPAX EPA & DHA (Omega 3) Ingredients Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 114. Algae EPAX EPA & DHA (Omega 3) Ingredients Product Portfolio Table 115. Algae EPAX Recent Development Table 116. Aker BioMarine Company Information Table 117. Aker BioMarine Business Overview Table 118. Aker BioMarine EPA & DHA (Omega 3) Ingredients Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 119. Aker BioMarine EPA & DHA (Omega 3) Ingredients Product Portfolio Table 120. Aker BioMarine Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. EPA & DHA (Omega 3) Ingredients Distributors List Table 124. EPA & DHA (Omega 3) Ingredients Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. EPA & DHA (Omega 3) Ingredients Product Image Figure 2. Global EPA & DHA (Omega 3) Ingredients Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032) & (US$ Million) Figure 4. Global EPA & DHA (Omega 3) Ingredients Sales (2021-2032) & (k tons) Figure 5. Global EPA & DHA (Omega 3) Ingredients Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global EPA & DHA (Omega 3) Ingredients Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Low Concentrates Image Figure 10. Anchovy/Sardine Image Figure 11. High Concentrates Image Figure 12. Salmon Oil Image Figure 13. Algae Oil Image Figure 14. Cod Liver Oil Image Figure 15. Medium Concentrates Image Figure 16. Global EPA & DHA (Omega 3) Ingredients Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 17. Global EPA & DHA (Omega 3) Ingredients Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Type (2021-2032) Figure 19. Global EPA & DHA (Omega 3) Ingredients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global EPA & DHA (Omega 3) Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Type (2021-2032) Figure 22. Infant Formulas Image Figure 23. Pharmaceuticals Image Figure 24. Dietary Supplements Image Figure 25. Functional Foods Image Figure 26. Pet & Animal Feed Image Figure 27. Global EPA & DHA (Omega 3) Ingredients Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 28. Global EPA & DHA (Omega 3) Ingredients Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Application (2021-2032) Figure 30. Global EPA & DHA (Omega 3) Ingredients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global EPA & DHA (Omega 3) Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Application (2021-2032) Figure 33. Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 34. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global EPA & DHA (Omega 3) Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032) & (US$ Million) Figure 38. North America EPA & DHA (Omega 3) Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032) & (US$ Million) Figure 40. Europe EPA & DHA (Omega 3) Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific EPA & DHA (Omega 3) Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032) & (US$ Million) Figure 44. South America EPA & DHA (Omega 3) Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. EPA & DHA (Omega 3) Ingredients Value Chain Figure 132. Manufacturing Cost Structure Figure 133. EPA & DHA (Omega 3) Ingredients Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • Low Concentrates
  • Anchovy/Sardine
  • High Concentrates
  • Salmon Oil
  • Algae Oil
  • Cod Liver Oil
  • Medium Concentrates
Applications
  • Infant Formulas
  • Pharmaceuticals
  • Dietary Supplements
  • Functional Foods
  • Pet & Animal Feed
Companies covered
  • Lonza
  • Omega Protein
  • Martek
  • GC Rieber Oils
  • DSM
  • Croda
  • BASF
  • Axellus
  • Algae EPAX
  • Aker BioMarine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032)
  4. 1.2.2 Global EPA & DHA (Omega 3) Ingredients Sales Volume (2021-2032)
  5. 1.2.3 Global EPA & DHA (Omega 3) Ingredients Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 EPA & DHA (Omega 3) Ingredients Market Dynamics
  1. 2.1 EPA & DHA (Omega 3) Ingredients Industry Trends
  2. 2.2 EPA & DHA (Omega 3) Ingredients Industry Drivers
  3. 2.3 EPA & DHA (Omega 3) Ingredients Industry Opportunities and Challenges
  4. 2.4 EPA & DHA (Omega 3) Ingredients Industry Restraints
3 EPA & DHA (Omega 3) Ingredients Market by Company
  1. 3.1 Global EPA & DHA (Omega 3) Ingredients Company Revenue Ranking in 2025
  2. 3.2 Global EPA & DHA (Omega 3) Ingredients Revenue by Company (2021-2026)
  3. 3.3 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Company (2021-2026)
  4. 3.4 Global EPA & DHA (Omega 3) Ingredients Average Price by Company (2021-2026)
  5. 3.5 Global EPA & DHA (Omega 3) Ingredients Company Ranking (2024-2026)
  6. 3.6 Global EPA & DHA (Omega 3) Ingredients Company Manufacturing Base and Headquarters
  7. 3.7 Global EPA & DHA (Omega 3) Ingredients Company Product Type and Application
  8. 3.8 Global EPA & DHA (Omega 3) Ingredients Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global EPA & DHA (Omega 3) Ingredients Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 EPA & DHA (Omega 3) Ingredients Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 EPA & DHA (Omega 3) Ingredients Market by Type
  1. 4.1 EPA & DHA (Omega 3) Ingredients Type Introduction
  2. 4.1.1 Low Concentrates
  3. 4.1.2 Anchovy/Sardine
  4. 4.1.3 High Concentrates
  5. 4.1.4 Salmon Oil
  6. 4.1.5 Algae Oil
  7. 4.1.6 Cod Liver Oil
  8. 4.1.7 Medium Concentrates
  9. 4.2 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Type
  10. 4.2.1 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Type (2021-2032)
  12. 4.2.3 Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Type (2021-2032)
  13. 4.3 Global EPA & DHA (Omega 3) Ingredients Sales Value by Type
  14. 4.3.1 Global EPA & DHA (Omega 3) Ingredients Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global EPA & DHA (Omega 3) Ingredients Sales Value by Type (2021-2032)
  16. 4.3.3 Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Type (2021-2032)
5 EPA & DHA (Omega 3) Ingredients Market by Application
  1. 5.1 EPA & DHA (Omega 3) Ingredients Application Introduction
  2. 5.1.1 Infant Formulas
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Functional Foods
  6. 5.1.5 Pet & Animal Feed
  7. 5.2 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Application
  8. 5.2.1 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Application (2021-2032)
  10. 5.2.3 Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Application (2021-2032)
  11. 5.3 Global EPA & DHA (Omega 3) Ingredients Sales Value by Application
  12. 5.3.1 Global EPA & DHA (Omega 3) Ingredients Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global EPA & DHA (Omega 3) Ingredients Sales Value by Application (2021-2032)
  14. 5.3.3 Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Application (2021-2032)
6 EPA & DHA (Omega 3) Ingredients Regional Sales and Value Analysis
  1. 6.1 Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global EPA & DHA (Omega 3) Ingredients Sales by Region (2021-2032)
  3. 6.2.1 Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2021-2026
  4. 6.2.2 Global EPA & DHA (Omega 3) Ingredients Sales by Region (2027-2032)
  5. 6.3 Global EPA & DHA (Omega 3) Ingredients Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global EPA & DHA (Omega 3) Ingredients Sales Value by Region (2021-2032)
  7. 6.4.1 Global EPA & DHA (Omega 3) Ingredients Sales Value by Region: 2021-2026
  8. 6.4.2 Global EPA & DHA (Omega 3) Ingredients Sales Value by Region (2027-2032)
  9. 6.5 Global EPA & DHA (Omega 3) Ingredients Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032)
  12. 6.6.2 North America EPA & DHA (Omega 3) Ingredients Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032)
  15. 6.7.2 Europe EPA & DHA (Omega 3) Ingredients Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific EPA & DHA (Omega 3) Ingredients Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032)
  21. 6.9.2 South America EPA & DHA (Omega 3) Ingredients Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Value Share by Country, 2025 VS 2032
7 EPA & DHA (Omega 3) Ingredients Country-level Sales and Value Analysis
  1. 7.1 Global EPA & DHA (Omega 3) Ingredients Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global EPA & DHA (Omega 3) Ingredients Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2032)
  4. 7.3.1 Global EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026)
  5. 7.3.2 Global EPA & DHA (Omega 3) Ingredients Sales by Country (2027-2032)
  6. 7.4 Global EPA & DHA (Omega 3) Ingredients Sales Value by Country (2021-2032)
  7. 7.4.1 Global EPA & DHA (Omega 3) Ingredients Sales Value by Country (2021-2026)
  8. 7.4.2 Global EPA & DHA (Omega 3) Ingredients Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza
  2. 8.1.1 Lonza Company Information
  3. 8.1.2 Lonza Business Overview
  4. 8.1.3 Lonza EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lonza EPA & DHA (Omega 3) Ingredients Product Portfolio
  6. 8.1.5 Lonza Recent Developments
  7. 8.2 Omega Protein
  8. 8.2.1 Omega Protein Company Information
  9. 8.2.2 Omega Protein Business Overview
  10. 8.2.3 Omega Protein EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Omega Protein EPA & DHA (Omega 3) Ingredients Product Portfolio
  12. 8.2.5 Omega Protein Recent Developments
  13. 8.3 Martek
  14. 8.3.1 Martek Company Information
  15. 8.3.2 Martek Business Overview
  16. 8.3.3 Martek EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Martek EPA & DHA (Omega 3) Ingredients Product Portfolio
  18. 8.3.5 Martek Recent Developments
  19. 8.4 GC Rieber Oils
  20. 8.4.1 GC Rieber Oils Company Information
  21. 8.4.2 GC Rieber Oils Business Overview
  22. 8.4.3 GC Rieber Oils EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GC Rieber Oils EPA & DHA (Omega 3) Ingredients Product Portfolio
  24. 8.4.5 GC Rieber Oils Recent Developments
  25. 8.5 DSM
  26. 8.5.1 DSM Company Information
  27. 8.5.2 DSM Business Overview
  28. 8.5.3 DSM EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DSM EPA & DHA (Omega 3) Ingredients Product Portfolio
  30. 8.5.5 DSM Recent Developments
  31. 8.6 Croda
  32. 8.6.1 Croda Company Information
  33. 8.6.2 Croda Business Overview
  34. 8.6.3 Croda EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Croda EPA & DHA (Omega 3) Ingredients Product Portfolio
  36. 8.6.5 Croda Recent Developments
  37. 8.7 BASF
  38. 8.7.1 BASF Company Information
  39. 8.7.2 BASF Business Overview
  40. 8.7.3 BASF EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BASF EPA & DHA (Omega 3) Ingredients Product Portfolio
  42. 8.7.5 BASF Recent Developments
  43. 8.8 Axellus
  44. 8.8.1 Axellus Company Information
  45. 8.8.2 Axellus Business Overview
  46. 8.8.3 Axellus EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Axellus EPA & DHA (Omega 3) Ingredients Product Portfolio
  48. 8.8.5 Axellus Recent Developments
  49. 8.9 Algae EPAX
  50. 8.9.1 Algae EPAX Company Information
  51. 8.9.2 Algae EPAX Business Overview
  52. 8.9.3 Algae EPAX EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Algae EPAX EPA & DHA (Omega 3) Ingredients Product Portfolio
  54. 8.9.5 Algae EPAX Recent Developments
  55. 8.10 Aker BioMarine
  56. 8.10.1 Aker BioMarine Company Information
  57. 8.10.2 Aker BioMarine Business Overview
  58. 8.10.3 Aker BioMarine EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Aker BioMarine EPA & DHA (Omega 3) Ingredients Product Portfolio
  60. 8.10.5 Aker BioMarine Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 EPA & DHA (Omega 3) Ingredients Value Chain Analysis
  2. 9.1.1 EPA & DHA (Omega 3) Ingredients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 EPA & DHA (Omega 3) Ingredients Sales Mode & Process
  6. 9.2 EPA & DHA (Omega 3) Ingredients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 EPA & DHA (Omega 3) Ingredients Distributors
  9. 9.2.3 EPA & DHA (Omega 3) Ingredients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst